Next Article in Journal
Facing Antibiotic Resistance: Staphylococcus aureus Phages as a Medical Tool
Next Article in Special Issue
Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
Previous Article in Journal
Seroprevalence of Human Herpesvirus 8 and Hepatitis C Virus among Drug Users in Shanghai, China
Previous Article in Special Issue
In the Shadow of Hemagglutinin: A Growing Interest in Influenza Viral Neuraminidase and Its Role as a Vaccine Antigen
Article Menu

Export Article

Open AccessReview
Viruses 2014, 6(7), 2531-2550;

RNA Virus Reverse Genetics and Vaccine Design

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA
Children's Healthcare of Atlanta, Atlanta, GA 30322, USA
Author to whom correspondence should be addressed.
Received: 30 April 2014 / Revised: 18 June 2014 / Accepted: 19 June 2014 / Published: 25 June 2014
(This article belongs to the Special Issue Virus-based Vaccines)
Full-Text   |   PDF [760 KB, uploaded 12 May 2015]   |  


RNA viruses are capable of rapid spread and severe or potentially lethal disease in both animals and humans. The development of reverse genetics systems for manipulation and study of RNA virus genomes has provided platforms for designing and optimizing viral mutants for vaccine development. Here, we review the impact of RNA virus reverse genetics systems on past and current efforts to design effective and safe viral therapeutics and vaccines. View Full-Text
Keywords: RNA virus; reverse genetics; vaccines RNA virus; reverse genetics; vaccines

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Stobart, C.C.; Moore, M.L. RNA Virus Reverse Genetics and Vaccine Design. Viruses 2014, 6, 2531-2550.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top